Finney strictureplasty
Finney strictureplasty is a surgical procedure used to treat intestinal obstruction caused by Crohn's disease. It is named after the American surgeon, John Miller Turpin Finney, who first described the procedure in 1902.
Overview[edit]
Crohn's disease is a chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract. One of the complications of Crohn's disease is the development of intestinal strictures, which are narrowings of the intestine that can cause obstruction. Finney strictureplasty is a surgical procedure that is used to widen these strictures without removing any part of the intestine.
Procedure[edit]
During a Finney strictureplasty, the surgeon makes a longitudinal incision along the length of the stricture. The incision is then closed in a transverse manner, effectively widening the lumen of the intestine. This procedure preserves the length of the intestine and avoids the need for intestinal resection, which can lead to short bowel syndrome.
Indications[edit]
Finney strictureplasty is indicated for patients with Crohn's disease who have developed short strictures in the small intestine. It is particularly useful for patients who have multiple strictures, as it allows for the treatment of all strictures in a single operation.
Risks and Complications[edit]
As with any surgical procedure, Finney strictureplasty carries some risks. These include infection, bleeding, and anastomotic leak. There is also a risk of recurrence of the stricture.
See Also[edit]
- Crohn's disease
- Intestinal obstruction
- Intestinal stricture
- Intestinal resection
- Short bowel syndrome
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
